ADNEXUS

Details for Australian Trade Mark No. 1252375 (hide)

Owner Adnexus, a Bristol-Myers Squibb R&D Company incorporated in the State

Service Spruson & Ferguson

Filing Date 17 July 2008

Classes

Class 5 Biotechnology and pharmaceutical products, including, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Event Publications

7 August 2008 Application filed

20 November 2008 Application Accepted

12 March 2009 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1252376

1252374